Advertisement
PULM vs TSHA
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PULM is a Hold and TSHA is a Hold.
Momentum Indicator for PULM turns positive, indicating new upward trend
PULM saw its Momentum Indicator move above the 0 level on October 23, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 103 similar instances where the indicator turned positive. In 77 of the 103 cases, the stock moved higher in the following days. The odds of a move higher are at 75%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 50 of 68 cases where PULM's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 74%.
The Moving Average Convergence Divergence (MACD) for PULM just turned positive on October 21, 2026. Looking at past instances where PULM's MACD turned positive, the stock continued to rise in 35 of 48 cases over the following month. The odds of a continued upward trend are 73%.
Following a +10.56% 3-day Advance, the price is estimated to grow further. Considering data from situations where PULM advanced for three days, in 166 of 231 cases, the price rose further within the following month. The odds of a continued upward trend are 72%.
Bearish Trend Analysis
The 10-day RSI Indicator for PULM moved out of overbought territory on September 23, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 22 similar instances where the indicator moved out of overbought territory. In 21 of the 22 cases, the stock moved lower in the following days. This puts the odds of a move lower at 90%.
PULM moved below its 50-day moving average on October 22, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for PULM crossed bearishly below the 50-day moving average on October 08, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 10 of 17 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 59%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where PULM declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 86%.
PULM broke above its upper Bollinger Band on September 21, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for PULM entered a downward trend on October 23, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 27 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 64 (best 1 - 100 worst), indicating steady price growth. PULM’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 75 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of 87 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.397) is normal, around the industry mean (3.043). P/E Ratio (-1.345) is within average values for comparable stocks, (-1.361). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (133.535) among similar stocks. PULM's P/S Ratio (2500.000) is slightly higher than the industry average of (438.009).
The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PULM’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
TSHA in upward trend: price may jump up because it broke its lower Bollinger Band on October 12, 2026
TSHA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 34 of 36 cases where TSHA's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 90%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where TSHA's RSI Indicator exited the oversold zone, 32 of 36 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 89%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 58 of 66 cases where TSHA's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 88%.
The Moving Average Convergence Divergence (MACD) for TSHA just turned positive on October 21, 2026. Looking at past instances where TSHA's MACD turned positive, the stock continued to rise in 38 of 43 cases over the following month. The odds of a continued upward trend are 88%.
Following a +4.57% 3-day Advance, the price is estimated to grow further. Considering data from situations where TSHA advanced for three days, in 216 of 265 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.
Bearish Trend Analysis
The 50-day moving average for TSHA moved below the 200-day moving average on October 14, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where TSHA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for TSHA entered a downward trend on October 23, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 17 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 21 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.332) is normal, around the industry mean (3.043). P/E Ratio (-9.659) is within average values for comparable stocks, (-1.361). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (133.535) among similar stocks. P/S Ratio (333.333) is also within normal values, averaging (438.009).
The Tickeron Price Growth Rating for this company is 82 (best 1 - 100 worst), indicating slightly worse than average price growth. TSHA’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. TSHA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
PULM | TSHA | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 21 | 12 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 87 Overvalued | 21 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 99 | 98 | |
PRICE GROWTH RATING 1..100 | 64 | 82 | |
P/E GROWTH RATING 1..100 | 27 | 17 | |
SEASONALITY SCORE 1..100 | 75 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
TSHA's Valuation (21) in the null industry is significantly better than the same rating for PULM (87) in the Biotechnology industry. This means that TSHA’s stock grew significantly faster than PULM’s over the last 12 months.
TSHA's Profit vs Risk Rating (100) in the null industry is in the same range as PULM (100) in the Biotechnology industry. This means that TSHA’s stock grew similarly to PULM’s over the last 12 months.
TSHA's SMR Rating (98) in the null industry is in the same range as PULM (99) in the Biotechnology industry. This means that TSHA’s stock grew similarly to PULM’s over the last 12 months.
PULM's Price Growth Rating (64) in the Biotechnology industry is in the same range as TSHA (82) in the null industry. This means that PULM’s stock grew similarly to TSHA’s over the last 12 months.
TSHA's P/E Growth Rating (17) in the null industry is in the same range as PULM (27) in the Biotechnology industry. This means that TSHA’s stock grew similarly to PULM’s over the last 12 months.
| PULM | TSHA | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 90% | 2 days ago 89% |
| Stochastic ODDS (%) | 2 days ago 74% | 2 days ago 88% |
| Momentum ODDS (%) | 2 days ago 75% | N/A |
| MACD ODDS (%) | 2 days ago 73% | 2 days ago 88% |
| TrendWeek ODDS (%) | 2 days ago 71% | 2 days ago 82% |
| TrendMonth ODDS (%) | 2 days ago 85% | 2 days ago 88% |
| Advances ODDS (%) | 4 days ago 72% | 4 days ago 82% |
| Declines ODDS (%) | 12 days ago 86% | 2 days ago 90% |
| BollingerBands ODDS (%) | 4 days ago 90% | 2 days ago 90% |
| Aroon ODDS (%) | 2 days ago 90% | 2 days ago 90% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
PULM’s FA Score shows that 1 FA rating(s) are green while TSHA’s FA Score has 2 green FA rating(s).
- PULM’s FA Score: 1 green, 4 red.
- TSHA’s FA Score: 2 green, 3 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
PULM’s TA Score shows that 4 TA indicator(s) are bullish while TSHA’s TA Score has 5 bullish TA indicator(s).
- PULM’s TA Score: 4 bullish, 6 bearish.
- TSHA’s TA Score: 5 bullish, 3 bearish.
Price Growth
PULM (@Biotechnology) experienced а +8.82% price change this week, while TSHA (@Biotechnology) price change was +9.39% for the same time period.
The average weekly price growth across all stocks in the @Biotechnology industry was +1.24%. For the same industry, the average monthly price growth was -16.30%, and the average quarterly price growth was -16.78%.
Reported Earning Dates
PULM is expected to report earnings on Oct 29, 2026.
TSHA is expected to report earnings on Nov 03, 2026.
Industries' Descriptions
@Biotechnology (+1.24% weekly)Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
Advertisement
TSHA and
Correlation & Price change
A.I.dvisor indicates that over the last year, TSHA has been loosely correlated with MGTX. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if TSHA jumps, then MGTX could also see price increases.
| Ticker / NAME | Correlation To TSHA | 1D Price Change % | ||
|---|---|---|---|---|
| TSHA | 100% | -1.12% | ||
| MGTX - TSHA | 52% Loosely correlated | -5.73% | ||
| SLDB - TSHA | 52% Loosely correlated | -4.36% | ||
| STOK - TSHA | 51% Loosely correlated | -2.57% | ||
| ABEO - TSHA | 51% Loosely correlated | -1.57% | ||
| LXEO - TSHA | 49% Loosely correlated | -3.11% | ||
More | ||||